Heart Failure with preserved Ejection Fraction (HFpEF), is a multifactorial disease associated with hypertension, diabetes and obesity, and is predominantly observed in females. HFpEF results in a slowly relaxing, fibrotic myocardium, and modifications in cardiomyocyte (CM) Ca²⁺-handling-proteins are observed in animal models in vivo. However, the role of cardiac fibroblasts (CFs) in the HFpEF phenotype remains unclear. This study aims to develop a HFpEF-like cellular model to explore abnormal Ca²⁺-signalling of CFs and CMs in diabetic-hypertensive conditions. Adult human male and female CFs (Promocell) and primary left ventricular CMs isolated from adult NZW male rabbits, were cultured independently or co-cultured using media containing 22 mM Glucose, 200 nM Angiotensin-II or a combination of both (to mimic diabetes, hypertension or HFpEF, respectively), for a duration of 24h. Both cell types were then loaded with 2µM Cal520AM calcium indicator. CFs were chemically stimulated using 20 nM Endothelin-1 while CMs were electrically field-stimulated at 1Hz to generate Ca²⁺-responses. The alterations in intracellular Ca²⁺ were measured by confocal microscopy. The Ca²⁺-transient-amplitude (ΔF/F₀) in CFs was enhanced with 22 mM Glucose [Control: 0.158±0.015; Diabetes: 0.273±0.014; n=3 humans with 3 technical replicates each; p< 0.001]. The Ca²⁺-transient-amplitude in CMs increased with Angiotensin-II [Control: 0.750±0.101; Hypertension: 2.02±0.32; N=3 rabbits; p< 0.0001]. In myocytes co-cultured with female CFs, the Ca²⁺-transient-amplitude was sustained with Glucose and Angiotensin-II [Control: 0.346±0.064; Diabetes: 0.359±0.049; Hypertension: 0.296±0.037; N=3 rabbits]. However, Ca²⁺-spark-frequency (sparks.µm².s⁻¹) in CMs was elevated after co-culture with female CFs, across all pathological conditions [Control: 3.56±0.71; Diabetes: 13.0±1.1; Hypertension: 16.5±1.1; HFpEF: 22.9±1.2; N=3 rabbits; p< 0.001]. These findings show remodelling of Ca²⁺-signalling in CFs and CMs, in an in vitro model of HFpEF. A sex disparity observed in female co-culture mimics that seen in human HFpEF. Further work is needed to understand how this in vitro model correlates to an in vivo model of HFpEF.
No takes yet. Share an insight, caveat, or question.
Olatunji et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: